Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patil

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Journal of Gastrointestinal Cancer|July 17, 2024
Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 YearsVanita Noronha, Anbarasan Sekar, Akhil Rajendra, et al.
Oncotarget|November 8, 2019
Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancerVijay Patil, Amit Joshi, Vanita Noronha, et al.
Oncotarget|April 2, 2021
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterationsAsim Joshi, Rohit Mishra, Sanket Desai, et al.
Ecancermedicalscience|June 10, 2022
Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income countryGoutam Panda, Arun Chandrasekharan, Shasanka Das, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 21, 2022
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastomaArchya Dasgupta, Tejpal Gupta, Madan Maitre, et al.
Pediatric Blood & Cancer|February 3, 2021
Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited settingTejpal Gupta, Shwetabh Sinha, Girish Chinnaswamy, et al.
Harmful Algae|August 20, 2025
Paralytic shellfish toxins and seabirds: evaluating sublethal effects, behavioral responses, and ecological implications of saxitoxin ingestion by common murres (Uria aalge)Matthew M Smith, Robert J Dusek, Tuula Hollmen, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Pediatric Blood & Cancer|May 15, 2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing countryJyoti Bajpai, Goutam Santosh Panda, Arun Chandrasekharan, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Journal of Gastrointestinal Cancer|July 17, 2024
Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 YearsVanita Noronha, Anbarasan Sekar, Akhil Rajendra, et al.
Oncotarget|November 8, 2019
Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancerVijay Patil, Amit Joshi, Vanita Noronha, et al.
Oncotarget|April 2, 2021
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterationsAsim Joshi, Rohit Mishra, Sanket Desai, et al.
Ecancermedicalscience|June 10, 2022
Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income countryGoutam Panda, Arun Chandrasekharan, Shasanka Das, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 21, 2022
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastomaArchya Dasgupta, Tejpal Gupta, Madan Maitre, et al.
Pediatric Blood & Cancer|February 3, 2021
Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited settingTejpal Gupta, Shwetabh Sinha, Girish Chinnaswamy, et al.
Harmful Algae|August 20, 2025
Paralytic shellfish toxins and seabirds: evaluating sublethal effects, behavioral responses, and ecological implications of saxitoxin ingestion by common murres (Uria aalge)Matthew M Smith, Robert J Dusek, Tuula Hollmen, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Pediatric Blood & Cancer|May 15, 2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing countryJyoti Bajpai, Goutam Santosh Panda, Arun Chandrasekharan, et al.
Pageof 19